Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. The studies were reported simultaneously ...

Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer Adult-onset neuroblastoma ...

Anaplastic thyroid cancer is the rarest type of thyroid cancer and the most challenging to treat. Anaplastic thyroid cancer cases are only 1% of all thyroid cancer cases, and the cure rate is low. The ...

Please provide your email address to receive an email when new articles are posted on . An updated guideline for best practices in managing anaplastic thyroid cancer stresses the need for ...

Overall survival rates for adults diagnosed with anaplastic thyroid carcinoma are similar between those with a history of cancer and those with no previous cancer diagnosis, according to findings ...

Medullary Thyroid Cancer - For the most part, when people think of thyroid cancer, they think of an easily treatable disease. The reality of the matter is that this is seldomly the case. Thyroid ...

Anaplastic thyroid carcinoma is one of the most aggressive and deadly cancers in humans and accounts for one to two cases per million persons annually. The rarity of this malignancy and the rapidity ...

NATICK, Mass.--(BUSINESS WIRE)--AffyImmune Therapeutics, a clinical-stage biotechnology company committed to developing novel, first-in-class CAR T cell therapies, today announced early results from a ...

The major anaplastic lymphoma kinase inhibitors market growth came from second-generation ALK inhibitors segment. The high prevalence of lung cancer, strong pipeline development, and recent approvals ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge. A recent review published in Genes & Diseases offers a comprehensive ...

We report here the cases of 4 male smokers with gynecomastia whose histories, physical examinations, laboratory studies, clinical courses and autopsy findings were typical of bronchogenic carcinoma.